Engineers Gate Manager
VOR icon

Engineers Gate Manager’s Vor Biopharma VOR Stock Holding History

Engineers Gate Manager’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680K Buy
36,951
+10,071
+37% +$152K 0.01% 1314
2026
Q1 		$480K Sell
26,880
-1,324
-5% -$18.7K 0.01% 1429
2025
Q4 		$369K Buy
+28,204
New +$525K ﹤0.01% 1514

Other funds holding VOR

TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCPM III Services
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Engineers Gate Manager's VOR Position: Q2 2026 in Review

Engineers Gate Manager increased its Vor Biopharma (VOR) stake by 37% in Q2 2026, buying an estimated $152K and bringing the position to 36,951 shares worth $680K. The position accounts for 0.01% of the portfolio, ranked #1314.

Engineers Gate Manager first reported a position in VOR in Q4 2025 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Engineers Gate Manager held 36,951 shares of Vor Biopharma worth $680K as of Q2 2026.
  • Engineers Gate Manager bought 10,071 Vor Biopharma shares in Q2 2026, an estimated $152K.
  • Vor Biopharma made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1314 holding.
  • Engineers Gate Manager first reported a position in Vor Biopharma in Q4 2025 and has held it in 3 quarters since.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.